CARDINAL HEALTH INC (CAH) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CAH • US14149Y1082

220.795 USD
-4.97 (-2.2%)
Last: Feb 10, 2026, 02:10 PM
Fundamental Rating

5

Overall CAH gets a fundamental rating of 5 out of 10. We evaluated CAH against 102 industry peers in the Health Care Providers & Services industry. CAH has an average financial health and profitability rating. CAH has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • CAH had positive earnings in the past year.
  • In the past year CAH had a positive cash flow from operations.
  • Of the past 5 years CAH 4 years were profitable.
  • CAH had a positive operating cash flow in each of the past 5 years.
CAH Yearly Net Income VS EBIT VS OCF VS FCFCAH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B

1.2 Ratios

  • With a decent Return On Assets value of 2.86%, CAH is doing good in the industry, outperforming 62.75% of the companies in the same industry.
  • CAH's Return On Invested Capital of 14.50% is amongst the best of the industry. CAH outperforms 92.16% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CAH is significantly above the industry average of 9.11%.
  • The 3 year average ROIC (14.18%) for CAH is below the current ROIC(14.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.86%
ROE N/A
ROIC 14.5%
ROA(3y)1.81%
ROA(5y)0.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)14.18%
ROIC(5y)11.92%
CAH Yearly ROA, ROE, ROICCAH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

1.3 Margins

  • The Profit Margin of CAH (0.68%) is comparable to the rest of the industry.
  • CAH has a Operating Margin (1.20%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CAH has remained more or less at the same level.
  • CAH has a Gross Margin of 3.70%. This is in the lower half of the industry: CAH underperforms 77.45% of its industry peers.
  • In the last couple of years the Gross Margin of CAH has declined.
Industry RankSector Rank
OM 1.2%
PM (TTM) 0.68%
GM 3.7%
OM growth 3Y6.46%
OM growth 5Y-0.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.56%
GM growth 5Y-3.96%
CAH Yearly Profit, Operating, Gross MarginsCAH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4

5

2. Health

2.1 Basic Checks

  • CAH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CAH has been reduced compared to 1 year ago.
  • CAH has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CAH is higher compared to a year ago.
CAH Yearly Shares OutstandingCAH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CAH Yearly Total Debt VS Total AssetsCAH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.2 Solvency

  • CAH has an Altman-Z score of 4.86. This indicates that CAH is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.86, CAH belongs to the best of the industry, outperforming 84.31% of the companies in the same industry.
  • CAH has a debt to FCF ratio of 1.64. This is a very positive value and a sign of high solvency as it would only need 1.64 years to pay back of all of its debts.
  • CAH has a Debt to FCF ratio of 1.64. This is amongst the best in the industry. CAH outperforms 84.31% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.64
Altman-Z 4.86
ROIC/WACC1.69
WACC8.6%
CAH Yearly LT Debt VS Equity VS FCFCAH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B 6B 8B

2.3 Liquidity

  • CAH has a Current Ratio of 0.91. This is a bad value and indicates that CAH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CAH has a worse Current ratio (0.91) than 74.51% of its industry peers.
  • A Quick Ratio of 0.44 indicates that CAH may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.44, CAH is doing worse than 86.27% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.44
CAH Yearly Current Assets VS Current LiabilitesCAH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

6

3. Growth

3.1 Past

  • CAH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.32%, which is quite impressive.
  • CAH shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.62% yearly.
  • The Revenue has grown by 10.13% in the past year. This is quite good.
  • Measured over the past years, CAH shows a small growth in Revenue. The Revenue has been growing by 7.80% on average per year.
EPS 1Y (TTM)24.32%
EPS 3Y17.65%
EPS 5Y8.62%
EPS Q2Q%36.27%
Revenue 1Y (TTM)10.13%
Revenue growth 3Y7.06%
Revenue growth 5Y7.8%
Sales Q2Q%18.75%

3.2 Future

  • CAH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.04% yearly.
  • Based on estimates for the next years, CAH will show a quite strong growth in Revenue. The Revenue will grow by 9.35% on average per year.
EPS Next Y22.63%
EPS Next 2Y17.64%
EPS Next 3Y15.65%
EPS Next 5Y13.04%
Revenue Next Year15.45%
Revenue Next 2Y12.32%
Revenue Next 3Y10.71%
Revenue Next 5Y9.35%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CAH Yearly Revenue VS EstimatesCAH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100B 200B 300B
CAH Yearly EPS VS EstimatesCAH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 22.98 indicates a rather expensive valuation of CAH.
  • Compared to the rest of the industry, the Price/Earnings ratio of CAH indicates a somewhat cheap valuation: CAH is cheaper than 64.71% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of CAH to the average of the S&P500 Index (28.06), we can say CAH is valued inline with the index average.
  • CAH is valuated rather expensively with a Price/Forward Earnings ratio of 19.36.
  • CAH's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CAH is cheaper than 61.76% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.86, CAH is valued a bit cheaper.
Industry RankSector Rank
PE 22.98
Fwd PE 19.36
CAH Price Earnings VS Forward Price EarningsCAH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • CAH's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, CAH is valued cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.53
EV/EBITDA 15.67
CAH Per share dataCAH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800 1K

4.3 Compensation for Growth

  • CAH's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CAH's earnings are expected to grow with 15.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.02
PEG (5Y)2.67
EPS Next 2Y17.64%
EPS Next 3Y15.65%

5

5. Dividend

5.1 Amount

  • CAH has a yearly dividend return of 0.90%, which is pretty low.
  • CAH's Dividend Yield is rather good when compared to the industry average which is at 0.47. CAH pays more dividend than 85.29% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, CAH's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.9%

5.2 History

  • The dividend of CAH has a limited annual growth rate of 1.25%.
  • CAH has paid a dividend for at least 10 years, which is a reliable track record.
  • CAH has decreased its dividend recently.
Dividend Growth(5Y)1.25%
Div Incr Years1
Div Non Decr Years1
CAH Yearly Dividends per shareCAH Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 29.78% of the earnings are spent on dividend by CAH. This is a low number and sustainable payout ratio.
  • The dividend of CAH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP29.78%
EPS Next 2Y17.64%
EPS Next 3Y15.65%
CAH Yearly Income VS Free CF VS DividendCAH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B
CAH Dividend Payout.CAH Dividend Payout, showing the Payout Ratio.CAH Dividend Payout.PayoutRetained Earnings

CARDINAL HEALTH INC

NYSE:CAH (2/10/2026, 2:10:28 PM)

220.795

-4.97 (-2.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-05
Earnings (Next)04-29
Inst Owners90.75%
Inst Owner Change-0.76%
Ins Owners0.22%
Ins Owner Change-0.35%
Market Cap52.46B
Revenue(TTM)244.67B
Net Income(TTM)1.66B
Analysts81.82
Price Target238.45 (8%)
Short Float %2.15%
Short Ratio2.57
Dividend
Industry RankSector Rank
Dividend Yield 0.9%
Yearly Dividend2.05
Dividend Growth(5Y)1.25%
DP29.78%
Div Incr Years1
Div Non Decr Years1
Ex-Date01-02
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.21%
Min EPS beat(2)10.57%
Max EPS beat(2)15.85%
EPS beat(4)4
Avg EPS beat(4)8.71%
Min EPS beat(4)1.06%
Max EPS beat(4)15.85%
EPS beat(8)8
Avg EPS beat(8)8.6%
EPS beat(12)12
Avg EPS beat(12)10.16%
EPS beat(16)14
Avg EPS beat(16)9.09%
Revenue beat(2)2
Avg Revenue beat(2)4.18%
Min Revenue beat(2)1.3%
Max Revenue beat(2)7.06%
Revenue beat(4)2
Avg Revenue beat(4)1.09%
Min Revenue beat(4)-2.15%
Max Revenue beat(4)7.06%
Revenue beat(8)4
Avg Revenue beat(8)0.44%
Revenue beat(12)6
Avg Revenue beat(12)0.27%
Revenue beat(16)10
Avg Revenue beat(16)0.79%
PT rev (1m)9.01%
PT rev (3m)28.69%
EPS NQ rev (1m)2.87%
EPS NQ rev (3m)3.15%
EPS NY rev (1m)1.8%
EPS NY rev (3m)3.92%
Revenue NQ rev (1m)-0.5%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)1.5%
Valuation
Industry RankSector Rank
PE 22.98
Fwd PE 19.36
P/S 0.21
P/FCF 9.53
P/OCF 8.6
P/B N/A
P/tB N/A
EV/EBITDA 15.67
EPS(TTM)9.61
EY4.35%
EPS(NY)11.4
Fwd EY5.16%
FCF(TTM)23.17
FCFY10.5%
OCF(TTM)25.69
OCFY11.63%
SpS1029.77
BVpS-12.14
TBVpS-70.97
PEG (NY)1.02
PEG (5Y)2.67
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.86%
ROE N/A
ROCE 19.91%
ROIC 14.5%
ROICexc 17.86%
ROICexgc N/A
OM 1.2%
PM (TTM) 0.68%
GM 3.7%
FCFM 2.25%
ROA(3y)1.81%
ROA(5y)0.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)14.18%
ROIC(5y)11.92%
ROICexc(3y)25.43%
ROICexc(5y)20.07%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.47%
ROCE(5y)16.36%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y7.19%
ROICexc growth 5Y14.1%
OM growth 3Y6.46%
OM growth 5Y-0.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.56%
GM growth 5Y-3.96%
F-Score7
Asset Turnover4.21
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.64
Debt/EBITDA 2.18
Cap/Depr 67.61%
Cap/Sales 0.24%
Interest Coverage 250
Cash Conversion 159.64%
Profit Quality 331.29%
Current Ratio 0.91
Quick Ratio 0.44
Altman-Z 4.86
F-Score7
WACC8.6%
ROIC/WACC1.69
Cap/Depr(3y)70.24%
Cap/Depr(5y)63.55%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.23%
Profit Quality(3y)467.85%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.32%
EPS 3Y17.65%
EPS 5Y8.62%
EPS Q2Q%36.27%
EPS Next Y22.63%
EPS Next 2Y17.64%
EPS Next 3Y15.65%
EPS Next 5Y13.04%
Revenue 1Y (TTM)10.13%
Revenue growth 3Y7.06%
Revenue growth 5Y7.8%
Sales Q2Q%18.75%
Revenue Next Year15.45%
Revenue Next 2Y12.32%
Revenue Next 3Y10.71%
Revenue Next 5Y9.35%
EBIT growth 1Y29.74%
EBIT growth 3Y13.98%
EBIT growth 5Y6.84%
EBIT Next Year41.95%
EBIT Next 3Y19.16%
EBIT Next 5YN/A
FCF growth 1Y60.71%
FCF growth 3Y-13.35%
FCF growth 5Y3.14%
OCF growth 1Y54.19%
OCF growth 3Y-9.47%
OCF growth 5Y4.11%

CARDINAL HEALTH INC / CAH FAQ

Can you provide the ChartMill fundamental rating for CARDINAL HEALTH INC?

ChartMill assigns a fundamental rating of 5 / 10 to CAH.


What is the valuation status for CAH stock?

ChartMill assigns a valuation rating of 5 / 10 to CARDINAL HEALTH INC (CAH). This can be considered as Fairly Valued.


How profitable is CARDINAL HEALTH INC (CAH) stock?

CARDINAL HEALTH INC (CAH) has a profitability rating of 5 / 10.


What is the expected EPS growth for CARDINAL HEALTH INC (CAH) stock?

The Earnings per Share (EPS) of CARDINAL HEALTH INC (CAH) is expected to grow by 22.63% in the next year.


How sustainable is the dividend of CARDINAL HEALTH INC (CAH) stock?

The dividend rating of CARDINAL HEALTH INC (CAH) is 5 / 10 and the dividend payout ratio is 29.78%.